News
GV20 Therapeutics (GV20), a clinical-stage AI-powered biotherapeutics company, has entered into a strategic research collaboration
Read more...Xcell Biosciences Australia Pty Ltd (Xcellbio), an Australian affiliate of the San Francisco-based instrumentation company focused on cell and gene therapy applications
Read more...27 March 2025
Primrose Bio, Inc. a company developing proprietary therapeutic manufacturing technologies, announces the launch of Prima RNApols™ ExTend
Read more...27 March 2025
Yoda Therapeutics Inc. (YODA), an AI-driven company that focuses on Central Nervous System (CNS) drugs
Read more...26 March 2025
SineuGene Therapeutics Co., Ltd. a clinical-stage biotech company pioneering innovative therapies for neurological disorders, today announced
Read more...26 March 2025
Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics
Read more...Actinium Pharmaceuticals, Inc. a pioneer in the development of targeted radiotherapies, today announced it has entered into an agreement for the supply
Read more...Sungen Biomedical's world-first new drug SGC001 monoclonal antibody receives FDA fast track approval
25 March 2025
US time, the world's first acute myocardial infarction (AMI) antibody drug, SGC001, developed by Sungen Biomedical
Read more...CStone Pharmaceuticals, a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission
Read more...Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, today announced that it has won the prestigious CMO Award for Life Science
Read more...